Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 20 | 2024 | 315 | 4.110 |
Why?
|
| Carcinoma, Pancreatic Ductal | 14 | 2024 | 104 | 2.770 |
Why?
|
| Cell Plasticity | 6 | 2024 | 15 | 1.480 |
Why?
|
| Neoplasms | 4 | 2024 | 1226 | 1.080 |
Why?
|
| Acinar Cells | 4 | 2024 | 8 | 1.020 |
Why?
|
| Tumor Escape | 1 | 2024 | 15 | 0.930 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 19 | 0.930 |
Why?
|
| Pancreatic Ducts | 4 | 2021 | 30 | 0.920 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2024 | 192 | 0.900 |
Why?
|
| Immune Evasion | 1 | 2024 | 53 | 0.890 |
Why?
|
| Cell Lineage | 1 | 2024 | 246 | 0.850 |
Why?
|
| Epithelial-Mesenchymal Transition | 6 | 2024 | 60 | 0.820 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 12 | 0.760 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2021 | 9 | 0.740 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 83 | 0.730 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 67 | 0.720 |
Why?
|
| Mice | 22 | 2024 | 10237 | 0.630 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2016 | 1 | 0.550 |
Why?
|
| Carcinogenesis | 4 | 2024 | 114 | 0.540 |
Why?
|
| Cell Line, Tumor | 12 | 2024 | 1366 | 0.540 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 59 | 0.540 |
Why?
|
| Stromal Cells | 1 | 2016 | 65 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2021 | 483 | 0.530 |
Why?
|
| Chemokines | 1 | 2016 | 94 | 0.520 |
Why?
|
| Metaplasia | 3 | 2024 | 18 | 0.510 |
Why?
|
| Animals | 25 | 2024 | 19561 | 0.490 |
Why?
|
| Neoplasm Metastasis | 5 | 2021 | 195 | 0.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 56 | 0.400 |
Why?
|
| Organoids | 2 | 2021 | 42 | 0.370 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2057 | 0.370 |
Why?
|
| Mice, Knockout | 6 | 2024 | 1984 | 0.370 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 642 | 0.360 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 321 | 0.360 |
Why?
|
| Pancreas | 5 | 2024 | 146 | 0.340 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 141 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3183 | 0.330 |
Why?
|
| Humans | 23 | 2024 | 59221 | 0.300 |
Why?
|
| Signal Transduction | 7 | 2024 | 2885 | 0.280 |
Why?
|
| Cellular Senescence | 2 | 2024 | 103 | 0.280 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 254 | 0.270 |
Why?
|
| Immunotherapy | 2 | 2024 | 225 | 0.250 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 274 | 0.250 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2024 | 3 | 0.240 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.240 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 1 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 53 | 0.230 |
Why?
|
| Cell Proliferation | 5 | 2020 | 940 | 0.220 |
Why?
|
| Immune Tolerance | 1 | 2024 | 169 | 0.220 |
Why?
|
| Sulfonamides | 1 | 2024 | 123 | 0.220 |
Why?
|
| Thermogenesis | 1 | 2024 | 108 | 0.220 |
Why?
|
| Hypoalbuminemia | 1 | 2023 | 6 | 0.220 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 100 | 0.220 |
Why?
|
| Steroid Hydroxylases | 1 | 2023 | 9 | 0.220 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 347 | 0.210 |
Why?
|
| Stress, Physiological | 1 | 2024 | 185 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 201 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 646 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2023 | 20 | 0.200 |
Why?
|
| Pancreatitis | 2 | 2024 | 101 | 0.200 |
Why?
|
| Genes, myc | 1 | 2021 | 19 | 0.190 |
Why?
|
| Fibroblasts | 3 | 2022 | 366 | 0.190 |
Why?
|
| Gene Deletion | 3 | 2019 | 298 | 0.190 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 47 | 0.190 |
Why?
|
| Protein Isoforms | 2 | 2019 | 193 | 0.190 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 69 | 0.190 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 350 | 0.180 |
Why?
|
| Histones | 1 | 2024 | 463 | 0.180 |
Why?
|
| Mice, Inbred Strains | 1 | 2021 | 183 | 0.180 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 77 | 0.180 |
Why?
|
| Immunity, Innate | 2 | 2024 | 764 | 0.180 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1290 | 0.180 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2019 | 1 | 0.170 |
Why?
|
| Calcium Signaling | 1 | 2021 | 152 | 0.170 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 14 | 0.170 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 55 | 0.160 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2019 | 5 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 127 | 0.160 |
Why?
|
| Carcinoma | 1 | 2019 | 116 | 0.160 |
Why?
|
| Regulon | 1 | 2018 | 6 | 0.160 |
Why?
|
| Stem Cells | 2 | 2018 | 254 | 0.160 |
Why?
|
| Catenins | 1 | 2018 | 9 | 0.160 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 8 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 496 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 71 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 545 | 0.150 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 399 | 0.150 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2017 | 6 | 0.150 |
Why?
|
| Keratin-15 | 1 | 2017 | 2 | 0.140 |
Why?
|
| Interleukins | 1 | 2017 | 77 | 0.140 |
Why?
|
| Interleukin-18 | 1 | 2017 | 74 | 0.140 |
Why?
|
| Esophagus | 1 | 2017 | 51 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 275 | 0.140 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 26 | 0.140 |
Why?
|
| Lymphocytes | 1 | 2017 | 193 | 0.140 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 221 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1128 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 53 | 0.130 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 6 | 0.130 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 14 | 0.130 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 13 | 0.130 |
Why?
|
| Collagen | 1 | 2016 | 121 | 0.130 |
Why?
|
| Phenotype | 2 | 2016 | 1154 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2017 | 295 | 0.130 |
Why?
|
| NF-kappa B | 1 | 2017 | 461 | 0.120 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 384 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 309 | 0.120 |
Why?
|
| Transcription Factors | 2 | 2023 | 1456 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 169 | 0.120 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 846 | 0.120 |
Why?
|
| Gene Expression | 1 | 2016 | 807 | 0.110 |
Why?
|
| Mice, Nude | 2 | 2024 | 258 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1534 | 0.100 |
Why?
|
| Female | 6 | 2024 | 30788 | 0.090 |
Why?
|
| Cadherins | 2 | 2021 | 67 | 0.080 |
Why?
|
| Cell Movement | 2 | 2021 | 421 | 0.070 |
Why?
|
| Regeneration | 2 | 2018 | 90 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2021 | 299 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 2424 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 35 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2018 | 374 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 25 | 0.060 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 20 | 0.060 |
Why?
|
| Cell Survival | 2 | 2017 | 552 | 0.060 |
Why?
|
| F-Box Proteins | 1 | 2024 | 15 | 0.060 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 18 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 656 | 0.060 |
Why?
|
| Male | 5 | 2024 | 27469 | 0.060 |
Why?
|
| Methylation | 1 | 2024 | 126 | 0.060 |
Why?
|
| Netrin Receptors | 1 | 2023 | 1 | 0.060 |
Why?
|
| Netrin-1 | 1 | 2023 | 4 | 0.060 |
Why?
|
| Retinoids | 1 | 2023 | 12 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1219 | 0.050 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2023 | 1 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2023 | 21 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 194 | 0.050 |
Why?
|
| Albumins | 1 | 2023 | 32 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 39 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 89 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2024 | 169 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2100 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 1038 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 740 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 180 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 58 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 958 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 124 | 0.040 |
Why?
|
| Etoposide | 1 | 2019 | 35 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2019 | 39 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2024 | 841 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 917 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 68 | 0.040 |
Why?
|
| Transcriptome | 1 | 2021 | 322 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 211 | 0.040 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 10 | 0.040 |
Why?
|
| Interleukin-15 | 1 | 2017 | 21 | 0.040 |
Why?
|
| Mucous Membrane | 1 | 2017 | 19 | 0.040 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 7 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 47 | 0.040 |
Why?
|
| DNA Repair | 1 | 2019 | 226 | 0.040 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 1 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 216 | 0.030 |
Why?
|
| L-Selectin | 1 | 2016 | 14 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2016 | 18 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2016 | 19 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 16 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 34 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 26 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 13284 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 568 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 47 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 188 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 291 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2016 | 41 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 180 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2015 | 19 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 28 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2016 | 111 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2016 | 170 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 62 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2015 | 53 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 453 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 253 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 118 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 118 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1137 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 259 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 846 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 340 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2011 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 787 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 509 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3094 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 808 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 196 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1036 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 861 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 676 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3564 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 16227 | 0.010 |
Why?
|